Instruction for useProduct Description:
A lateral flow immunochromatographic assay for the rapid qualitative
detection of dengue virus NS1 antigen in human whole blood, serum or
plasma
Features:
- Product Name: Dengue NS1 Ag Rapid Test
- Assay Time: 1 Hour
- Storage Temperature: 2-30°C
- Test Type:Rapid Test
- Manufacturer: Biovantion
- Country of Origin: China
- Features:
- Immunoassay Test Kit for Serological Detection
- Antigen-Antibody Binding Test Kit for Rapid Test
Technical Parameters:
| Manufacturer: |
Biovantion |
| Product Name: |
Dengue NS1 Ag Rapid Test |
| Test Type: |
Enzyme-Linked Immunosorbent Assay Test Kit |
| Kit Size: |
96 Tests |
| Assay Time: |
1 Hour |
| Storage Temperature: |
2-30°C |
| Specificity: |
High |
| Sensitivity: |
High |
| Shelf Life: |
18 Months |
| Country of Origin: |
China |
| Keywords: |
ELISA Assay Kit for Medical Diagnosis, Immunoassay Test Kit for Serological Detection |
INTENDED USE
The EUGENE® Dengue NS1 Rapid Test Device is a lateral flow
chromatographic immunoassay for the qualitative detection of
dengue virus antigen (Dengue Ag) in human whole blood, serum
or plasma. It is intended to be used as a screening test and as an
aid in the diagnosis of infection with Dengue viruses. Any reactive
specimen with the Dengue NS1 Rapid Test Device must be
confirmed with alternative testing method(s) and clinical findings.
SUMMARY
Dengue viruses, a family of four distinct serotypes of viruses
(Den 1,2,3,4), are single-strained, enveloped, positive-sense
RNA viruses. The viruses are transmitted by mosquitoes of
the daytime-bitting Stegemyia family, principally Aedes aegypti,
and Aedes albopictus. Today, more than 2.5 billion people living
in the areas of tropical Asia, Africa, Australia, and the Americas
are at risk for dengue infection. An estimated 100 million cases
of dengue fever and 250,000 cases of life-threatening dengue
hemorrhagic fever occur annually on a worldwide basis.
Serological detection of IgM antibody is the most common
method for the diagnosis of dengue virus infection. Lately,
detection of antigens released during virus replication in the
infected patient showed very promising result. It enables
diagnosis from the first day after the onset of fever up to day 9,
once the clinical phase of the disease is over, thus allows early
treatment in placed promptly.
The Dengue NS1 Rapid Test is developed to detect circulating
dengue antigen in serum, plasma or whole blood. The test can
be performed by untrained or minimally skilled personnel,
without laboratory equipment.
